Muscle Atrophy in Patients With Severe Sepsis
This study is being done to help determine whether patients with severe sepsis (overwhelming inflammation in the body as a result of an infection) lose muscle and become weak more rapidly than patients with other severe illnesses. Weakness and muscle loss that develops after a severe illness is a serious problem. Patients who develop weakness and have a decrease in muscle size often have to stay in the hospital longer and have a higher chance of dying. At the current time, it is not clear whether certain severe illnesses are more likely to cause weakness and muscle loss. This study will be done to measure the changes in muscle size and strength as a result of each patient's illness
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Muscle Atrophy in Patients With Severe Sepsis|
- Quadriceps muscle cross sectional area change from day 0 to 7 [ Time Frame: seven days ] [ Designated as safety issue: No ]Serial measures of quadriceps muscle by non-invasive ultrasound on Day of enrollment and Day 7 after enrollment
|Study Start Date:||December 2011|
|Study Completion Date:||February 2013|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|
a CPM (continuous passive motion) device attached to one of your legs intermittently over the next three days.
An optional portion of the study is available to help determine if moving the leg repeatedly with a mechanical device helps prevent muscle loss and weakness. In this optional portion of the study, the subject would have a CPM (continuous passive motion) device attached to one of the subject's legs intermittently over the next three days. Without any effort from the subject , the machine would move the subjects leg back and forth (flexing at the hip and the knee) repeatedly.
This machine is approved by the United States Food and Drug Administration (FDA) to treat patients after they have knee replacement surgery to help preserve the range of motion of the joint while minimizing risk of damage to the joint from more intensive exercise. The use of the device for this study is investigational.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01717651
|United States, Ohio|
|The Ohio State University Medical Center - University Hospital|
|Columbus, Ohio, United States, 43210|
|Principal Investigator:||Naeem A Ali, MD||Ohio State University|